CDSCO panel approves Sanofi's proposal to increase number of subjects from 25 to 40 in india to study SAR443122 Written By Dr. Divya Colin5 Jan 2025 5:45 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has granted approval to the drug...
Sanofi appoints Jean-Paul Kress as Independent Director Ruchika Sharma21 Dec 2024 12:30 PM ISTParis: Sanofi has announced the appointment of Jean-Paul Kress as an Independent Director, effective January 1, 2025. Jean-Paul Kress will...
Sanofi gets USFDA Breakthrough Therapy designation for multiple sclerosis therapy Tolebrutinib Ruchika Sharma17 Dec 2024 11:32 AM ISTParis: Sanofi has announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to Tolebrutinib for the...
USFDA grants Breakthrough Therapy designation to Sanofi tolebrutinib for non-relapsing secondary progressive multiple sclerosis Written By Ruchika Sharma13 Dec 2024 3:53 PM ISTParis: Sanofi has announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to tolebrutinib...
Two Sanofi combination vaccine candidates for prevention of influenza, COVID gets USFDA Fast Track designation Written By Ruchika Sharma11 Dec 2024 12:25 PM ISTParis: The US Food and Drug Administration (USFDA) has granted Fast Track designation to two Sanofi combination vaccine candidates to prevent...
Sanofi, Regeneron Dupixent sBLA accepted for USFDA review for chronic spontaneous urticaria Written By Ruchika Sharma17 Nov 2024 4:15 PM ISTParis: Sanofi and Regeneron has announced that the US Food and Drug Administration (FDA) has accepted for review the resubmission of the...
Sarclisa recommended for EU approval by CHMP to treat transplant-ineligible newly diagnosed multiple myeloma: Sanofi Written By Ruchika Sharma17 Nov 2024 4:00 PM ISTParis: Sanofi has announced that the European Medicines Agency (EMA)'s Committee for Medicinal Products for Human Use (CHMP) has adopted a...
Sanofi Gets CDSCO Panel Nod to Study Venglustat Written By Dr. Divya Colin13 Nov 2024 5:00 PM ISTNew Delhi: Reviewing the Phase III clinical trial protocol of the GZ402671 (Venglustat) presented by the pharma major Sanofi, the Subject Expert...
Sanofi, Regeneron Dupixent approved in EU for young children with eosinophilic esophagitis Written By Ruchika Sharma7 Nov 2024 3:55 PM ISTParis: Sanofi has announced that the European Medicines Agency has approved Dupixent (dupilumab) to treat eosinophilic esophagitis (EoE) in...
Sanofi Healthcare Gets CDSCO Panel Nod to Study Asthma Drug SAR443765 Written By Dr. Divya Colin3 Nov 2024 5:15 PM ISTNew Delhi: The drug major Sanofi Healthcare has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
CDSCO panel approves Sanofi Healthcare's protocol amendment proposal to study SAR441566 Written By Dr. Divya Colin1 Nov 2024 5:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has granted approval to the drug...
Sanofi gets CDSCO Panel nod to study Amlitelimab Written By Dr. Divya Colin31 Oct 2024 5:30 PM ISTNew Delhi: The drug major Sanofi has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
